CCME Global Limited (BSE: 514336)
Health Care · Biotechnology · IN
Rs37.09
+15.44% today · -69.7% 1Y
CCME Global Limited (BSE: 514336) operates in the Biotechnology industry within the Health Care sector. The company is valued at $17.68M.
Over the last twelve months the share price has lost 69.7%, trading between 26.41 and 184.90.
Tweenvest scores CCME Global Limited across four factors: quality 55/100, value 63/100. Its strongest factor is value.
514336 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.68M
- Revenue (TTM)
- $3.75K
- P/E
- —
- EPS
- -0.41
- Dividend yield
- —
- Beta (5Y)
- 0.37
- 52-week high
- Rs184.90
- 52-week low
- Rs26.41
- Avg volume (3M)
- —
- Shares outstanding
- 45.25M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Akari Therapeutics, PlcNasdaqCM: AKTX | $18.69M | $8.18 | -6.73% |
| Kyntra Bio, Inc.NasdaqGS: KYNB | $18.55M | $4.58 | -12.26% |
| Defence Therapeutics Inc.CNSX: DTC | $18.22M | CA$0.34 | -15.00% |
| Neuphoria Therapeutics Inc.NasdaqGM: NEUP | $17.86M | $3.30 | -1.79% |
| Perseus Proteomics Inc.TSE: 4882 | $17.63M | ¥151.00 | -1.31% |
| Marker Therapeutics, Inc.NasdaqCM: MRKR | $17.34M | $1.04 | +7.04% |
| Diamyd Medical AB (publ)OM: DMYD B | $17.06M | Skr1.09 | +11.22% |
| TaiwanJ Pharmaceuticals Co., Ltd.TPEX: 6549 | $17.01M | NT$6.89 | -2.13% |
Figures last refreshed Oct 18, 2026.